ID: ALA4466132

Max Phase: Preclinical

Molecular Formula: C29H44N2O2

Molecular Weight: 452.68

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCNC(=O)[C@H]1CC[C@@]2(C)CC[C@@H]3c4ccc(OCCCN5CCC[C@H]5C)cc4CC[C@H]3[C@H]12

Standard InChI:  InChI=1S/C29H44N2O2/c1-4-30-28(32)26-13-15-29(3)14-12-24-23-11-9-22(19-21(23)8-10-25(24)27(26)29)33-18-6-17-31-16-5-7-20(31)2/h9,11,19-20,24-27H,4-8,10,12-18H2,1-3H3,(H,30,32)/t20-,24-,25-,26+,27-,29-/m1/s1

Standard InChI Key:  BNBNRRZULRWOQK-GIKUPPRISA-N

Associated Targets(Human)

HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hrh3 Histamine H3 receptor (2579 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm1 Muscarinic acetylcholine receptor (3770 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 452.68Molecular Weight (Monoisotopic): 452.3403AlogP: 5.55#Rotatable Bonds: 7
Polar Surface Area: 41.57Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.72CX LogP: 5.02CX LogD: 2.73
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.55Np Likeness Score: 0.07

References

1. Ledneczki I, Némethy Z, Tapolcsányi P, Éles J, Greiner I, Gábor E, Varga B, Balázs O, Román V, Lévay G, Mahó S..  (2019)  Discovery of novel steroidal histamine H3 receptor antagonists/inverse agonists. Part 2. Versatile steroidal carboxamide derivatives.,  29  (20): [PMID:31492518] [10.1016/j.bmcl.2019.126643]

Source